<p>Arterial glucose concentrations (Panel A); glucose infusion rate (GIR; Panel B) and tissue (soleus, gastrocnemius, superficial vastus lateralis (SVL), heart, and brain) glucose uptake (Panel C), and fold-change from basal of insulin-stimulated glucose uptake (Panel D) during a hyperinsulinemic-euglycemic clamp in chronically catheterized 5-hour fasted C57/BL6j mice that received vehicle (VEH), low-dose LPS (LD LPS; 1 µg/gBW), or high-dose LPS (HD LPS; 10 µg/gBW),. Data are expressed as mean±SEM. * p<0.05 vs. VEH, # p<0.05 vs. LD LPS.</p
<p>Mice received the indicated sample treatments for 5 weeks. Diabetes was induced by multiple (for ...
Portal infusion of glucose in the mouse at a rate equivalent to basal endogenous glucose production ...
<p>Glucose disposal curves in response to an iv injection of 1 g/kg D50 administered over 15 sec at ...
<p>Basal arterial glucose concentrations (Panel A) and tissue glucose uptake (Panel B) in chronicall...
<p>Arterial plasma insulin levels in response to vehicle, low- (1 µg/gBW), or high- (10 µg/gBW) dose...
<p>Glucose (A), glucose infusion rate (GIR 60–90 min) (B) and plasma insulin levels (C) during the c...
<p>A 90 min phloridzin (80 μg·kg<sup>−1</sup>·min<sup>−1</sup>)-glucose (115 mg·dL<sup>−1</sup>) cla...
<p>Akt phosphorylation (Ser<sup>473</sup>; Panel A) and GSK phosphorylation (Panel B) in the gastroc...
Despite increased use of the hyperinsulinemic-euglycemic clamp to study insulin action in mice, the ...
<p>Mean ± SEM for (A) body weight, (B) food intake over 24 hrs prior to lipopolysaccharide (LPS; 1 m...
A, E: Blood glucose was monitored throughout the clamp at 10-min intervals by sampling from the arte...
<p>The hyperinsulinemic euglycemic clamp was performed in HIF-1α ASO treated and untreated mice (C, ...
Lipopolysaccharide (LPS) elicits a strong immune response, which leads to the release of inflammator...
<p><b>A</b>: Plasma TG (g/l). <b>B</b>: FFA (mM). <b>C</b>: Plasma portal GLP1 concentration (pM) at...
<p><b>A</b>, Hyperinsulinemic-euglycemic clamp tests were performed in both groups to analyze insuli...
<p>Mice received the indicated sample treatments for 5 weeks. Diabetes was induced by multiple (for ...
Portal infusion of glucose in the mouse at a rate equivalent to basal endogenous glucose production ...
<p>Glucose disposal curves in response to an iv injection of 1 g/kg D50 administered over 15 sec at ...
<p>Basal arterial glucose concentrations (Panel A) and tissue glucose uptake (Panel B) in chronicall...
<p>Arterial plasma insulin levels in response to vehicle, low- (1 µg/gBW), or high- (10 µg/gBW) dose...
<p>Glucose (A), glucose infusion rate (GIR 60–90 min) (B) and plasma insulin levels (C) during the c...
<p>A 90 min phloridzin (80 μg·kg<sup>−1</sup>·min<sup>−1</sup>)-glucose (115 mg·dL<sup>−1</sup>) cla...
<p>Akt phosphorylation (Ser<sup>473</sup>; Panel A) and GSK phosphorylation (Panel B) in the gastroc...
Despite increased use of the hyperinsulinemic-euglycemic clamp to study insulin action in mice, the ...
<p>Mean ± SEM for (A) body weight, (B) food intake over 24 hrs prior to lipopolysaccharide (LPS; 1 m...
A, E: Blood glucose was monitored throughout the clamp at 10-min intervals by sampling from the arte...
<p>The hyperinsulinemic euglycemic clamp was performed in HIF-1α ASO treated and untreated mice (C, ...
Lipopolysaccharide (LPS) elicits a strong immune response, which leads to the release of inflammator...
<p><b>A</b>: Plasma TG (g/l). <b>B</b>: FFA (mM). <b>C</b>: Plasma portal GLP1 concentration (pM) at...
<p><b>A</b>, Hyperinsulinemic-euglycemic clamp tests were performed in both groups to analyze insuli...
<p>Mice received the indicated sample treatments for 5 weeks. Diabetes was induced by multiple (for ...
Portal infusion of glucose in the mouse at a rate equivalent to basal endogenous glucose production ...
<p>Glucose disposal curves in response to an iv injection of 1 g/kg D50 administered over 15 sec at ...